Your position:www.healthoo.com >> EN >> EN >> Pharmaceutical News >> Jiangxi Tianxin Pharmaceutical's revenue in the first half of 2024 was 1.067 billion yuan, and calcium pantothenate products achieved mass production. >> article
 
Jiangxi Tianxin Pharmaceutical's revenue in the first half of 2024 was 1.067 billion yuan, and calcium pantothenate products achieved mass production.
Editor:xuezhe     Clicks:0    Date:2024/9/5 15:24:31
Keyword: calcium pantothenate
Healthoo Information:
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • Some domestic manufacturers raise the price of calcium pantothenate.
  • Calcium pantothenate (feed) quoted prices of main producers
  • Calcium pantothenate (feed) quoted prices of main producers
  • Calcium pantothenate (feed) quoted prices of main producers
  • Calcium pantothenate (feed) quoted prices of main producers
  • Atorvastatin Calcium reference price
  • Rosuvastatin Calcium reference export price
  • Calcium pantothenate (feed) quoted prices of main producers
  • Xinfa pharmaceutical "D- calcium pantothenate" products successfully e...
  • Calcium pantothenate (feed) quoted prices of main producers
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463